8.90 USD
↘ 0.45 (4.77%)AT CLOSE (AS OF 07:38 PM EDT)
Sutro Biopharma, Inc.
STRONASDAQ • USD
Market: CLOSED
Sutro Biopharma, Inc. (STRO) trades at $8.90 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (174.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, STRO appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$9.32
High?$9.43
Low?$8.11
Prev. Close?$9.33
Volume?694.5K
Avg. Volume?360.3K
VWAP?$8.62
Rel. Volume?1.93x
Bid / Ask
Bid?$7.50 × 100
Ask?$9.11 × 300
Spread?$1.61
Midpoint?$8.31
Valuation & Ratios
Market Cap?147.4M
Shares Out?16.6M
Float?15.0M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?-1.43
EPS?-$10.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Themes
Employees
128
Market Cap
154.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-09-27
Address
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?50
Short Sent.?29
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.77Distress
Confidence?58%Low
Short InterestHigh
Short % of Float?13.06%High
Short Interest?2.0M
Days to Cover?6.3
Free Float15.0M
Avg Daily Volume313.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.32Strong
Quick Ratio?3.32Strong
Cash Ratio?1.03Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?-1.43CHEAP▾
S&P97
P/S?3.23FAIR▾
Peers100
S&P47
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?2.04CHEAP▾
Peers100
S&P74
Returns & Efficiency
ROE?174.8%STRONG▾
Peers50
S&P97
ROA?-92.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-145619000
Enterprise Value?$93.1M
Fundamentals ratios updated end of day